Cite

HARVARD Citation

    Majd, N. et al. (2020). Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study. Journal for immunotherapy of cancer. 8 (2), p. . [Online]. 
  
Back to record